Huo C, Baek J, Kim K
J Ginseng Res. 2025; 49(2):105-117.
PMID: 40061485
PMC: 11889387.
DOI: 10.1016/j.jgr.2024.12.004.
Koceva H, Amiratashani M, Akbarimoghaddam P, Hoffmann B, Zhurgenbayeva G, Gresnigt M
Open Biol. 2025; 15(3):240231.
PMID: 40037530
PMC: 11879621.
DOI: 10.1098/rsob.240231.
Zawiasa-Bryszewska A, Nowicka M, Gorska M, Edyko P, Edyko K, Tworek D
Vaccines (Basel). 2025; 13(2).
PMID: 40006735
PMC: 11861709.
DOI: 10.3390/vaccines13020189.
Chang M, Shi S, Jin Y, Wang G, Peng R, An J
Pathogens. 2025; 14(2).
PMID: 40005519
PMC: 11858400.
DOI: 10.3390/pathogens14020142.
Saha A, Ganguly A, Kumar A, Srivastava N, Pathak R
Pathogens. 2025; 14(2).
PMID: 40005506
PMC: 11858160.
DOI: 10.3390/pathogens14020129.
Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination drives Th2-skewed response and is reduced with age.
Noureddine M, Chang L, Chang L, El Ayache F, El-Ayache F, Laghlali G
Res Sq. 2025; .
PMID: 39975920
PMC: 11838721.
DOI: 10.21203/rs.3.rs-5760877/v1.
Antiviral activity of silver nanoparticles against H1N1 influenza virus.
Seyfi M, Letafati A, Edalat F, Shatizadeh Malekshahi S, Pirbonyeh N, Moattari A
BMC Res Notes. 2025; 18(1):75.
PMID: 39966976
PMC: 11834247.
DOI: 10.1186/s13104-025-07143-0.
Comparison of Respiratory Microbiomes in Influenza Versus Other Respiratory Infections: Systematic Review and Analysis.
Hao Y, Lee Y, Yap K, Samuel M, Chow V
Int J Mol Sci. 2025; 26(2).
PMID: 39859492
PMC: 11765715.
DOI: 10.3390/ijms26020778.
No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysis.
Miller I, Mumau M, Shyamsundar S, Sarmiento Bustamante M, Horna P, Gonzalez M
Sci Rep. 2025; 15(1):1676.
PMID: 39799155
PMC: 11724840.
DOI: 10.1038/s41598-025-85193-x.
Respiratory Virus-Specific and Time-Dependent Interference of Adenovirus Type 2, SARS-CoV-2 and Influenza Virus H1N1pdm09 During Viral Dual Co-Infection and Superinfection In Vitro.
Stincarelli M, Arvia R, Guidotti B, Giannecchini S
Viruses. 2025; 16(12.
PMID: 39772252
PMC: 11680187.
DOI: 10.3390/v16121947.
The Impact of Vaccinations Against Respiratory Infections on the Prognosis in Heart Failure Patients.
Jankowiak B, Wleklik M, Rosiek-Biegus M
Vaccines (Basel). 2025; 12(12.
PMID: 39771983
PMC: 11679989.
DOI: 10.3390/vaccines12121321.
Quantitative assessment of Public Health and Social Measures implementation and relaxation on influenza transmission during COVID-19 in China: SEIABR and GBDT models.
He Y, Luo K, Ni H, Kuang W, Fu L, Yi S
J Glob Health. 2024; 14:05038.
PMID: 39727104
PMC: 11672222.
DOI: 10.7189/jogh.14.05038.
Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice.
DeDiego M, Portilla Y, Daviu N, Lopez-Garcia D, Villamayor L, Vazquez-Utrilla P
Int J Nanomedicine. 2024; 19:13763-13788.
PMID: 39723174
PMC: 11669338.
DOI: 10.2147/IJN.S475323.
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen.
Verhoeven D, Sponseller B, Crowe Jr J, Bangaru S, Webby R, Lee B
NPJ Vaccines. 2024; 9(1):247.
PMID: 39702334
PMC: 11659547.
DOI: 10.1038/s41541-024-01037-1.
Prevalence and Surveillance of Influenza Viruses in Hospitalized Patients with Respiratory Infections in and Around Chennai, Southern Part of India.
Sabapathy S, Narasimhachar S, Kuppuswamy A
Indian J Microbiol. 2024; 64(4):1551-1557.
PMID: 39678962
PMC: 11645399.
DOI: 10.1007/s12088-023-01168-4.
Influenza A virus continues to circulate among children in Linyi, northern China, after the relaxation of COVID-19 control measures.
Lv T, Chen J, Li H, Chen X, Zhang N, Ma C
Sci Rep. 2024; 14(1):30164.
PMID: 39627283
PMC: 11615383.
DOI: 10.1038/s41598-024-81542-4.
Research trends and hotspots on global influenza and inflammatory response based on bibliometrics.
Li H, Zong Y, Li J, Zhou Z, Chang Y, Shi W
Virol J. 2024; 21(1):313.
PMID: 39623458
PMC: 11613568.
DOI: 10.1186/s12985-024-02588-4.
Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection.
Xu S, Zhao Z, Sun C, Ji Y, Luan Q, Zhang Q
Poult Sci. 2024; 104(1):104559.
PMID: 39603189
PMC: 11635735.
DOI: 10.1016/j.psj.2024.104559.
CaMKII-dependent non-canonical RIG-I pathway promotes influenza virus propagation in the acute-phase of infection.
Hama S, Watanabe-Takahashi M, Nishimura H, Omi J, Tamada M, Saitoh T
mBio. 2024; 16(1):e0008724.
PMID: 39601535
PMC: 11708044.
DOI: 10.1128/mbio.00087-24.
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies.
Muthukutty P, MacDonald J, Yoo S
Vaccines (Basel). 2024; 12(11).
PMID: 39591123
PMC: 11598775.
DOI: 10.3390/vaccines12111220.